Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-May-11 5:07 PM View:  | Spagnardi Joseph M Senior VP, GC & Secretary | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 20,000 | $5.00 | $100,000.00 | (100%) 20.0K to 0 | (< 1%) |
| 16-May-11 6:19 PM View: | Schachle Joseph K EVP, Pulmonary Business | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 20,000 | $5.00 | $100,000.00 | (99%) 20.15K to 0.15K | (< 1%) |
| 16-May-11 5:07 PM View: | Staab Thomas R II EVP, CFO & Treasurer | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 20,000 | $5.00 | $100,000.00 | (91%) 22.0K to 2.0K | (< 1%) |
| 16-May-11 5:50 PM View: | Leff Jonathan S Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) Duplicate | 22,907,500 | $5.00 | $114,537,000.00 | (100%) 22.91M to 0 | (< 1%) |
| 16-May-11 1:30 PM View: | Warburg Pincus Private Equi... 10% Owner | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 22,907,500 | $5.00 | $114,537,000.00 | (100%) 22.91M to 0 | (< 1%) |
| 16-May-11 10:00 PM View: | Lee Kenneth B Jr Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 2,400 | $5.00 | $12,000.00 | (100%) 2.4K to 0 | (< 1%) |
| 16-May-11 6:24 PM View: | Adams Adrian President and CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 446,875 | $5.00 | $2,234,380.00 | (69%) 650.0K to 203.13K | (< 1%) |
| 16-May-11 6:19 PM View: | Schachle Joseph K EVP, Pulmonary Business | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 150 | $5.00 | $750.00 | (100%) 0.15K to 0 | (< 1%) |
| 16-May-11 5:07 PM View: | Staab Thomas R II EVP, CFO & Treasurer | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 2,000 | $5.00 | $10,000.00 | (100%) 2.0K to 0 | (< 1%) |
| 16-May-11 6:24 PM View: | Adams Adrian President and CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 203,125 | $5.00 | $1,015,620.00 | (100%) 203.13K to 0 | (< 1%) |
| 16-May-11 10:00 PM View: | Abercrombie George B Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 1,099 | $5.00 | $5,495.00 | (100%) 1.1K to 0 | (< 1%) |
| 16-May-11 6:11 PM View: | Koven Andrew I EVP & Chief Admin & Legal Ofc | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 142,779 | $5.00 | $713,895.00 | (100%) 142.78K to 0 | (< 1%) |
| 16-May-11 10:00 PM View: | Frey Kip Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) Duplicate | 2,000 | $5.00 | $10,000.00 | (100%) 2.0K to 0 | (< 1%) |
| 16-May-11 10:00 PM View: | Hutson Nancy J Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 14,800 | $5.00 | $74,000.00 | (100%) 14.8K to 0 | (< 1%) |
| 16-May-11 5:11 PM View: | Brazzell Kim EVP, Medical & Scientific | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 20,000 | $5.00 | $100,000.00 | (100%) 20.0K to 0 | (< 1%) |
| 16-May-11 5:08 PM View: | Holmer Alan F Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 3,000 | $5.00 | $15,000.00 | (100%) 3.0K to 0 | (< 1%) |
| 17-Nov-10 12:04 PM View: | Frey Kip Director | Inspire Pharmaceuticals, Inc. (ISPH) | 15-Nov-10 | Market Option Sale | 7,934 | $7.27 | $57,697.80 | (80%) 9.93K to 2.0K | 2% |
| 17-Nov-10 12:04 PM View: | Frey Kip Director | Inspire Pharmaceuticals, Inc. (ISPH) | 15-Nov-10 | Option Exercise | 7,934 | $2.76 | $21,897.80 | 397% 2.0K to 9.93K | |
| 12-Nov-10 10:02 AM View: | Hutson Nancy J Director | Inspire Pharmaceuticals, Inc. (ISPH) | 09-Nov-10 | Market Purchase | 7,000 | $6.99 | $48,914.00 | 90% 7.8K to 14.8K | < 1% |
| 07-Jun-10 4:56 PM View: | Abercrombie George B Director | Inspire Pharmaceuticals, Inc. (ISPH) | 03-Jun-10 | Payment of Exercise | 493 | $5.82 | $2,869.26 | (31%) 1.59K to 1.1K | 8% |
| 07-Jun-10 4:56 PM View: | Abercrombie George B Director | Inspire Pharmaceuticals, Inc. (ISPH) | 03-Jun-10 | Option Exercise | 1,592 | -- | -- | 100% 0 to 1.59K | |
| 21-May-10 10:32 AM View: | Koven Andrew I EVP & Chief Admin & Legal Ofc | Inspire Pharmaceuticals, Inc. (ISPH) | 19-May-10 | Payment of Exercise | 107,221 | $6.04 | $647,615.00 | (43%) 250.0K to 142.78K | 4% |
| 21-May-10 10:32 AM View: | Koven Andrew I EVP & Chief Admin & Legal Ofc | Inspire Pharmaceuticals, Inc. (ISPH) | 19-May-10 | Option Exercise | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 05-May-10 2:55 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 03-May-10 | Market Sale (Planned) | 2,000 | $6.74 | $13,471.10 | (4%) 54.26K to 52.26K | (8%) |
| 05-Apr-10 5:25 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Apr-10 | Market Sale (Planned) | 2,000 | $6.30 | $12,602.30 | (4%) 56.26K to 54.26K | 1% |
| 19-Mar-10 11:22 AM View: | Adams Adrian President and CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 18-Mar-10 | Grant | 650,000 | -- | -- | 100% 0 to 650.0K | |
| 03-Mar-10 12:02 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Mar-10 | Market Sale (Planned) | 2,000 | $6.14 | $12,282.20 | (3%) 58.26K to 56.26K | (2%) |
| 02-Feb-10 4:02 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Feb-10 | Market Sale (Planned) | 2,000 | $5.41 | $10,821.90 | (3%) 60.26K to 58.26K | (< 1%) |
| 05-Jan-10 2:36 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 04-Jan-10 | Market Sale (Planned) | 2,000 | $5.61 | $11,211.10 | (3%) 62.26K to 60.26K | (3%) |
| 08-Dec-09 2:46 PM View: | Shaffer Christy L President & CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 08-Dec-09 | Market Sale (Planned) | 3,500 | $6.00 | $21,000.00 | (< 1%) 360.8K to 357.3K | 0% |
| 08-Dec-09 2:46 PM View: | Shaffer Christy L President & CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 07-Dec-09 | Market Sale (Planned) | 1,500 | $6.00 | $9,000.00 | (< 1%) 362.3K to 360.8K | 0% |
| 02-Dec-09 3:25 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Dec-09 | Market Sale (Planned) | 2,000 | $5.70 | $11,395.10 | (3%) 64.26K to 62.26K | (3%) |
| 03-Nov-09 1:28 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 02-Nov-09 | Market Sale (Planned) | 2,000 | $4.56 | $9,112.00 | (3%) 66.26K to 64.26K | < 1% |
| 01-Oct-09 4:42 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Oct-09 | Market Sale (Planned) | 2,000 | $5.20 | $10,401.00 | (3%) 68.26K to 66.26K | (< 1%) |
| 01-Sep-09 5:04 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Sep-09 | Market Sale (Planned) | 2,000 | $5.68 | $11,357.00 | (3%) 70.26K to 68.26K | (5%) |
| 25-Aug-09 3:06 PM View: | Shaffer Christy L President & CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 24-Aug-09 | Market Sale (Planned) | 10,000 | $6.02 | $60,237.00 | (3%) 372.3K to 362.3K | < 1% |
| 10-Aug-09 5:03 PM View: | Leff Jonathan S Director | Inspire Pharmaceuticals, Inc. (ISPH) | 10-Aug-09 | Market Purchase Duplicate | 8,888,890 | $4.50 | $40,000,000.00 | 63% 14.02M to 22.91M | 2% |
| 10-Aug-09 5:04 PM View: | Warburg Pincus Private Equi... 10% Owner | Inspire Pharmaceuticals, Inc. (ISPH) | 10-Aug-09 | Market Purchase | 8,888,890 | $4.50 | $40,000,000.00 | 63% 14.02M to 22.91M | 2% |
| 03-Aug-09 5:10 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 03-Aug-09 | Market Sale (Planned) | 2,000 | $4.82 | $9,637.44 | (3%) 72.26K to 70.26K | (< 1%) |
| 02-Jul-09 10:58 AM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 01-Jul-09 | Market Sale (Planned) | 2,000 | $5.62 | $11,241.00 | (3%) 74.26K to 72.26K | 2% |
| 16-Jun-09 10:56 AM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 15-Jun-09 | Market Sale | 6,125 | $4.99 | $30,542.20 | (8%) 80.38K to 74.26K | |
| 12-Nov-08 9:54 AM View: | Frey Kip Director | Inspire Pharmaceuticals, Inc. (ISPH) | 10-Nov-08 | Market Purchase | 2,000 | $3.40 | $6,800.00 | 100% 0 to 2.0K | (6%) |
| 06-Nov-08 4:38 PM View: | Lee Kenneth B Jr Director | Inspire Pharmaceuticals, Inc. (ISPH) | 04-Nov-08 | Market Purchase | 2,000 | $3.88 | $7,759.40 | 500% 0.4K to 2.4K | (8%) |
| 06-Nov-08 4:36 PM View: | Yerxa Benjamin R EVP & Chf, Research & Develop | Inspire Pharmaceuticals, Inc. (ISPH) | 04-Nov-08 | Option Exercise | 9,131 | $0.42 | $3,835.02 | 13% 71.25K to 80.38K | 748% |
| 23-Jul-08 2:13 PM View: | Kellerman Donald J Senior VP, Development | Inspire Pharmaceuticals, Inc. (ISPH) | 21-Jul-08 | Disposition | 12,000 | -- | -- | (59%) 20.3K to 8.3K | |
| 15-May-08 12:55 PM View: | Yerxa Benjamin R Chf Sci Off & EVP Strat Ops | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-08 | Option Exercise | 23,126 | $0.28 | $6,563.76 | 48% 48.13K to 71.25K | 1144% |
| 14-Nov-07 4:27 PM View: | Shaffer Christy L President & CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 13-Nov-07 | Market Sale (Planned) | 5,000 | $6.03 | $30,132.10 | (1%) 377.3K to 372.3K | 9% |
| 01-Nov-07 4:02 PM View: | Leff Jonathan S Director | Inspire Pharmaceuticals, Inc. (ISPH) | 31-Oct-07 | Conversion Duplicate | 14,018,600 | -- | -- | 100% 0 to 14.02M | |
| 01-Nov-07 4:01 PM View: | Warburg Pincus Private Equi... 10% Owner | Inspire Pharmaceuticals, Inc. (ISPH) | 31-Oct-07 | Conversion | 14,018,600 | -- | -- | 100% 0 to 14.02M | |
| 10-Sep-07 4:20 PM View: | Shaffer Christy L President & CEO Director | Inspire Pharmaceuticals, Inc. (ISPH) | 06-Sep-07 | Market Sale (Planned) | 5,000 | $6.00 | $30,000.00 | (1%) 382.3K to 377.3K | 9% |
